Literatur
-
1
Genton P.
When antiepileptic drugs aggravate epilepsy.
Brain Dev.
2000;
22
75-80
-
2
Genton P.
Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?.
Neurology.
2000;
55
1106-1109
-
3
Lortie A, Chiron C, Mumford J, Dulac O.
The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.
Neurology.
1993;
43, Suppl 5
S24-S27
-
4
Tassinari C A, Dravet C, Roger J. et al .
Tonic status epilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome.
Epilepsia.
1972;
13
421-435
-
5
Snead O C, Hosey L C.
Exacerbation of seizures in children by carbamazepine.
N Engl J Med.
1985;
313
916-921
-
6
Elger C E, Bauer J, Scherrmann J, Widman G.
Aggravation of focal epileptic seizures by antiepileptic drugs.
Epilepsia.
1998;
39, Suppl 3
15-18
-
7
Hosford D A, Wang Y.
Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
Epilepsia.
1997;
38
408-414
-
8
Hosford D A, Clark S, Cao Z. et al .
The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice.
Science.
1992;
257
398-401
-
9
Schapel G, Chadwick D.
Tiagabine and non-convulsive status epilepticus.
Seizure.
1996;
5
153-156
-
10
Eckhardt K M, Steinhoff B J.
Nonconvulsive status epilepticus in two patients receiving tiagabine treatment.
Epilepsia.
1998;
39
671-674
-
11
Holtkamp M, Buchheim K, Pfeiffer M, Meierkord H.
Tiagabin und nonkonvulsiver Status epilepticus.
Nervenarzt.
1999;
70
1104-1106
-
12
Knake S, Hamer H M, Schomburg U. et al .
Tiagabine-induced absence status in idiopathic generalized epilepsy.
Seizure.
1999;
8
314-317
-
13
Walton N Y, Gunawan S, Treiman D M.
Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine.
Epilepsy Res.
1994;
19
237-244
-
14
Pfeiffer M, Draguhn A, Meierkord H, Heinemann U.
Effects of γ-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro.
Br J Pharmacol.
1996;
119
569-577
Dr. med. Martin Holtkamp
Neurologische Klinik und Poliklinik · Charité · Humboldt-Universität Berlin
Augustenburger Platz 1
13353 Berlin
